MPM BioImpact’s Phathom Pharmaceuticals PHAT Stock Holding History

MPM BioImpact’s Portfolio PHAT Stock Details PHAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$639K	Sell
2023 Q3	$3.6M	Buy
2023 Q2	$4.04M	Buy
2023 Q1	$1.52M	Buy
2022 Q4	$2.2M	Buy
2022 Q3	$2.14M	Hold
2022 Q2	$1.63M	Hold
2022 Q1	$2.63M	Buy